These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 3965136

  • 1. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE.
    Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ, Howe ML.
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [Abstract] [Full Text] [Related]

  • 3. Relationship of success in classical immunotherapy to the relative immunorejective strength of the tumor.
    Reif AE.
    J Natl Cancer Inst; 1986 Oct; 77(4):899-908. PubMed ID: 3020300
    [Abstract] [Full Text] [Related]

  • 4. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 5. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
    Rogers MJ, Galetto G, Hearing VJ, Siwarski DF, Law LW.
    J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
    [Abstract] [Full Text] [Related]

  • 6. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V, Hilbert D, Wolff L.
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [Abstract] [Full Text] [Related]

  • 8. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
    Jiang D, Flyer DC.
    J Immunol; 1992 Feb 01; 148(3):974-80. PubMed ID: 1730885
    [Abstract] [Full Text] [Related]

  • 9. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
    Flyer DC, Burakoff SJ, Faller DV.
    J Immunol; 1986 Dec 15; 137(12):3968-72. PubMed ID: 3491152
    [Abstract] [Full Text] [Related]

  • 10. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA, Mayer AM, Pasqualini CD.
    Cancer Res; 1977 Jun 15; 37(6):1768-76. PubMed ID: 192461
    [Abstract] [Full Text] [Related]

  • 11. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC, Kirchner H, Rodrigues D, Park JY, Herberman RB.
    J Immunol; 1976 Jan 15; 116(1):244-52. PubMed ID: 54388
    [Abstract] [Full Text] [Related]

  • 12. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Einstein AB, Fass L, Fefer A.
    Cancer Res; 1975 Mar 15; 35(3):492-6. PubMed ID: 1078784
    [Abstract] [Full Text] [Related]

  • 13. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P, Biasi G, Horvath C, Cerottini JC, MacDonald HR.
    J Immunol; 1998 Feb 15; 160(4):1659-65. PubMed ID: 9469422
    [Abstract] [Full Text] [Related]

  • 14. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
    Al-Ghazzouli IK, Donahoe RM, Huang KY, Sass B, Peters RL, Kelloff GJ.
    J Immunol; 1976 Dec 15; 117(6):2239-48. PubMed ID: 186539
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B.
    Vaccine; 2007 Mar 01; 25(11):2145-54. PubMed ID: 17254672
    [Abstract] [Full Text] [Related]

  • 16. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW.
    Cancer Res; 1976 Dec 01; 36(12):4552-7. PubMed ID: 1000500
    [Abstract] [Full Text] [Related]

  • 17. Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens.
    Ting CC, Law LW.
    J Immunol; 1977 Apr 01; 118(4):1259-64. PubMed ID: 191534
    [Abstract] [Full Text] [Related]

  • 18. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A, Ito Y.
    Cancer Res; 1972 Nov 01; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract] [Full Text] [Related]

  • 19. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA, Ciavarra R, Riblet R, Forman J.
    J Immunol; 1984 Nov 01; 133(5):2778-85. PubMed ID: 6434638
    [Abstract] [Full Text] [Related]

  • 20. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
    Atencio IA, Belli B, Hobbs M, Cheng SF, Villarreal LP, Fan H.
    Virology; 1995 Oct 01; 212(2):356-66. PubMed ID: 7571405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.